Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-24-132708
Filing Date
2024-12-31
Accepted
2024-12-31 08:39:46
Documents
1
Period of Report
2024-12-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2432277-1_3aseq1.html 3/A  
1 OWNERSHIP DOCUMENT tm2432277-1_3aseq1.xml 3/A 8451
  Complete submission text file 0001104659-24-132708.txt   10211
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Issuer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BARINTHUS BIOTHERAPEUTICS PLC UNIT 6-10, ZEUS BUILDING RUTHERFORD AVE HARWELL, DIDCOT X0 OX11 0DF
Business Address
Lynn Geoffrey (Reporting) CIK: 0002049206 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-40367 | Film No.: 241591235